The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 2, 2015, Pages 407-412

  Namazy, Jennifer ^a   Cabana, Michael D ^b   Scheuerle, Angela E ^c   Thorp, John M ^d   Chen, Hubert ^e   Carrigan, Gillis ^e   Wang, Yan ^e   Veith, Joachim ^e   Andrews, Elizabeth B ^f  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Tesserae Genetics Texas   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e GENENTECH INC   (United States)

^f RTI HEALTH SOLUTIONS   (United States)

Author keywords

moderate to severe persistent allergic asthma; Omalizumab; pregnancy

Indexed keywords

OMALIZUMAB; ANTIASTHMATIC AGENT; ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; ANKYLOGLOSSIA; ARTERIOVENOUS MALFORMATION; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CRYPTORCHISM; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; HYDROCELE; HYPOSPADIAS; INGUINAL HERNIA; LOW BIRTH WEIGHT; NEONATAL THROMBOCYTOPENIA; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PIGMENTED NEVUS; PLAGIOCEPHALY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; UMBILICAL HERNIA; URTICARIA PIGMENTOSA; VESICOURETERAL REFLUX; ADOLESCENT; CONGENITAL ABNORMALITIES; ENVIRONMENTAL EXPOSURE; GESTATIONAL AGE; INFANT; MIDDLE AGED; NEWBORN; PRENATAL EXPOSURE; REGISTER; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CONGENITAL ABNORMALITIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL EXPOSURE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84922380947     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.08.025     Document Type: Article

References (35)

1. H.L. Kwon, E.W. Triche, K. Belanger, and M.B. Bracken The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms Immunol Allergy Clin North Am 26 2006 29 62
2. L. Blais, F.Z. Kettani, N. Elftouh, and A. Forget Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study Birth Defects Res A Clin Mol Teratol 88 2010 216 222
3. K. Demissie, M.B. Breckenridge, and G.G. Rhoads Infant and maternal outcomes in the pregnancies of asthmatic women Am J Respir Crit Care Med 158 1998 1091 1095
4. National Heart Lung and Blood Institute NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update J Allergy Clin Immunol 115 2005 34 46
5. R. Rahimi, S. Nikfar, and M. Abdollahi Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review Hum Exp Toxicol 25 2006 447 452
6. M. Schatz, R.S. Zeiger, K. Harden, C.C. Hoffman, L. Chilingar, and D. Petitti The safety of asthma and allergy medications during pregnancy J Allergy Clin Immunol 100 1997 301 306
7. L.J. Tata, S.A. Lewis, T.M. McKeever, C.J. Smith, P. Doyle, and L. Smeeth Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study Thorax 63 2008 981 987
8. A. Lim, K. Stewart, K. Konig, and J. George Systematic review of the safety of regular preventive asthma medications during pregnancy Ann Pharmacother 45 2011 931 945
9. Genentech Inc. XOLAIR [omalizumab]: Full Prescribing Information. 2010.
10. European Medicines Agency. Xolair: European Public Assessment Report (EPAR). 2013.
11. A. Scheuerle, and H. Tilson Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry Pharmacoepidemiol Drug Saf 11 2002 465 475
12. V.E. Murphy, P. Gibson, P.I. Talbot, and V.L. Clifton Severe asthma exacerbations during pregnancy Obstet Gynecol 106 2005 1046 1054
13. M. Schatz, R.S. Zeiger, and C.P. Hoffman Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group Chest 98 1990 389 392
14. M. Schatz, R.S. Zeiger, C.P. Hoffman, K. Harden, A. Forsythe, and L. Chilingar Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis Am J Respir Crit Care Med 151 1995 1170 1174
15. L.N. Bakhireva, K.L. Jones, M. Schatz, H.S. Klonoff-Cohen, D. Johnson, and D.J. Slymen Safety of leukotriene receptor antagonists in pregnancy J Allergy Clin Immunol 119 2007 618 625
16. L. Blais, M.F. Beauchesne, C. Lemiere, and N. Elftouh High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations J Allergy Clin Immunol 124 2009 1229 1234.e4
17. L. Blais, M.F. Beauchesne, E. Rey, J.L. Malo, and A. Forget Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma Thorax 62 2007 320 328
18. B. Pasternak, H. Svanstrom, and A. Hviid Ondansetron in pregnancy and risk of adverse fetal outcomes N Engl J Med 368 2013 814 823
19. M. MacDorman, S. Kirmeyer, and E. Wilson Fetal and perinatal mortality, United States, 2006 2012 Centers for Disease Control and Prevention Bethesda, Md 1 23
20. L.J. Tata, S.A. Lewis, T.M. McKeever, C.J. Smith, P. Doyle, and L. Smeeth A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma Am J Respir Crit Care Med 175 2007 991 997
21. V.E. Murphy, J.A. Namazy, H. Powell, M. Schatz, C. Chambers, and J. Attia A meta-analysis of adverse perinatal outcomes in women with asthma BJOG 118 2011 1314 1323
22. J.A. Namazy, V.E. Murphy, H. Powell, P.G. Gibson, C. Chambers, and M. Schatz Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes Eur Respir J 41 2013 1082 1090
23. QuickStats: Percentage of small-for-gestational-age births, by race and Hispanic ethnicity - United States, 2005 MMWR Morb Mortal Wkly Rep 57 2008 1359
24. J. Martin, B. Hamilton, S. Ventura, M. Osterman, and T. Mathews Births: Final Data for 2011 2013 Centers for Disease Control and Prevention Bethesda, MD 1 70
25. L. Rynn, J. Cragan, and A. Correa Update on overall prevalence of major birth defects - Atlanta, Georgia, 1978-2005 MMWR Morb Mortal Wkly Rep 57 2008 1 5
26. M. Sarkar, G. Koren, S. Kalra, A. Ying, C. Smorlesi, and M. De Santis Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes Eur J Clin Pharmacol 65 2009 1259 1264
27. E. Sheiner, M. Mazor, A. Levy, A. Wiznitzer, and A. Bashiri Pregnancy outcome of asthmatic patients: a population-based study J Matern Fetal Neonatal Med 18 2005 237 240
28. L. Ammon Avalos, C. Galindo, and D.K. Li A systematic review to calculate background miscarriage rates using life table analysis Birth Defects Res A Clin Mol Teratol 94 2012 417 423
29. S. Lin, J.P. Munsie, M.L. Herdt-Losavio, C.M. Druschel, K. Campbell, and M.L. Browne Maternal asthma medication use and the risk of selected birth defects Pediatrics 129 2012 e317 e324
30. S.E. Parker, C.T. Mai, M.A. Canfield, R. Rickard, Y. Wang, and R.E. Meyer Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006 Birth Defects Res A Clin Mol Teratol 88 2010 1008 1016
31. G.R. Alexander, J.H. Himes, R.B. Kaufman, J. Mor, and M. Kogan A United States national reference for fetal growth Obstet Gynecol 87 1996 163 168
32. A. Correa, J.D. Cragan, J.E. Kucik, C.J. Alverson, S.M. Gilboa, and R. Balakrishnan Reporting birth defects surveillance data 1968-2003 Birth Defects Res A Clin Mol Teratol 79 2007 65 186
33. California Birth Defects Monitoring Program Birth Defects in California: 1983-1990 1994 California Department of Public Health Sacramento
34. Congenital Malformation Registry Statistical Summary of Children Born in 1983-2007 2013 New York State Department of Health Albany
35. Texas Birth Defects Registry Report of Birth Defects Among 2000-2009 Deliveries, Table 1. Prevalence of Selected Birth Defects, Texas, 2000-2009 2012 Texas Department of State Health Austin, Tex